Publication Date:
2013-08-08
Description:
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies Leukemia 27, 1628 (August 2013). doi:10.1038/leu.2013.38 Authors: D J DeAngelo, A Spencer, K N Bhalla, H M Prince, T Fischer, T Kindler, F J Giles, J W Scott, K Parker, A Liu, M Woo, P Atadja, K K Mishra & O G Ottmann
Keywords:
panobinostathistone deacetylasemyelofibrosisHodgkin lymphomamyelodysplastic disordersmyeloma
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink